Buck Institute – COVID 19 Perspectives Buck Institute – COVID 19 Perspectives

Kevin Tracey, MD

President & CEO, Feinstein Institutes for Medical Research

Recorded: Thursday, June 18, 2020

Share this event

About

Join Dr. Kevin Tracey, live Thursday, June 18, 2020, as he shares his perspective on ways to think about, deal with, and potentially treat the COVID-19 pandemic.

An expert in the methodology of drug testing, Dr. Kevin Tracey is the President and CEO of the Feinstein Institutes for Medical Research in Manhasset, NY, part of the Northwell School of Medicine at Hofstra University. He received his MD from Boston University and trained as a neurosurgeon at New York Hospital. He has led the Feinstein Institutes since 2005.

Dr. Tracey’s expertise in neuroscience and research on the molecular basis of inflammation led to the founding of the bioelectronics field, which seeks to modulate inflammation through electronic stimulation of neurons. He is recognized as one of the most-cited researchers in the world. As head of the Feinstein Institutes, Dr. Tracey is playing in a role in clinical trials run in partnership between Northwell Health and the pharmaceutical companies Gilead Sciences, Regeneron Pharmaceuticals, and Sanofi.

Questions

Get ready to join Dr. Kevin Tracey in conversation, Thursday, June 18th.

In the meantime, we invite you to take a moment now to help shape this upcoming conversation.

Check out the list of questions submitted by other registered attendees, and then vote to support any that match your interests.

Feel free to add your own question. Then spread the word to make sure others have the chance to help move your question to the top of the shared list.

  • 7

    votes

    Which drug holds the most promise ( other than Dexamethasone ) in this page http://www.marininfo.org/Healthcare/COVID-19/Drugs_Trials_COVID19.htm

  • 5

    votes

    If we believe there is a possibility that we may have been exposed to the virus, is there anything we can do to try to prevent it from developing.

  • 3

    votes

    Can you please explain the latest thinking on the relation between COVID-19 and inflammation?

  • 2

    votes

    Can you please clarify the mortality rate of this virus compared to the flu? My naysayer friends keep insisting the mortality is not much worse than the flu and we are over-reacting and ruining lives.

  • 2

    votes

    Austria has no masks, restaurants are open, even a demonstration called no uptick. What is your explanation?

  • 2

    votes

    Was Dexamethasone only effective in the trial with late stage patients, and by intravenous administration? There must be millions of people who were on oral steroids during this pandemic. Can their medical status re COVID-19 be assessed?

  • 2

    votes

    Can we get real stats? If you test 100 people how many are positive for coved ? And of the positive how many will show symptoms and get very sick ? I see many people with masks covering only their mouths. Is that safe to be around ?

  • 2

    votes

    I’m afraid I don’t understand the mechanics of clinical trials. Could you walk us through, for example, how what you’re doing is proceeding? And what the right timeline is to look for some benefit from your efforts?

  • 2

    votes

    Can you describe what you’re seeing in clinical trials?

  • 2

    votes

    Things seem to be settling down some now. What does the research tell us about what to expect through the end of the year and beyond?

  • 1

    votes

    Does sickle cell trait influence the outcome of Covid19 disease?

  • 0

    votes

    There have been a few unpublished reports of very low Vitamin D levels in darker skin people with poor COVID 19 outcomes. Does your system have Vitamin D data. Any interest in a future study?

  • 0

    votes

    Would taking Rituxan for CLL make you more susceptible to Covid19?

Ask a Question

Your email address will not be published.